Morning Breakouts

Latest KFF Health News Stories

Former CMS Administrators Press Senate To Delay Making Changes To Medicaid

Morning Briefing

Andy Slavitt, who worked for President Barack Obama, and Gail Wilensky, who worked for President George H.W. Bush, urge lawmakers to take a more deliberate review of Medicaid issues. “Congress can and should commit to improving and modernizing Medicaid, but the process will take time to develop bipartisan support for the changes that are needed and should not be rushed,” they wrote.

Nearly 70 Percent Of Republican Voters Want GOP To Continue Repeal Efforts

Morning Briefing

The poll also suggests that Republicans want Senate GOP leaders to shift gears and work with Democrats to pass a new health care bill. But a separate poll also finds that health care is not necessarily going to be the only deciding factor in the elections.

There’s No Real Buy-In From Republicans On Bill Making It Tough To Get To 50 Votes

Morning Briefing

The response has been tepid at best on the legislation, and lawmakers are struggling to get something they’ve been promising for seven years out the door. The New York Times offers a look at where they’re still divided, while the Los Angeles Times considers what a fix to Obamacare would like.

The Last Draft Of GOP’s Bill Failed — So What’s Different This Time?

Morning Briefing

Media outlets look at the changes leadership has made to try to woo senators, such as adding the option to let insurers sell cheaper, skinny plans. But one thing that hasn’t been touched? The unpopular Medicaid cuts.

Scientists Stumble Upon Potential Vaccine For Gonorrhea At Best Possible Time

Morning Briefing

In an era where the sexually transmitted disease is becoming increasingly difficult to treat because of antibiotic resistance, researchers find that a vaccine for meningitis may also protect against gonorrhea. In other public health news: cervical cancer, sunscreen, double-booked surgeons, brain training, pigs’ knees and more.

After Trump Meets With Pharma CEO, FDA Yanks Request For Company To Run Additional Drug Trial

Morning Briefing

Instead, Amicus Therapeutics gets the go-ahead by the agency to submit its treatment of a deadly rare disease for review. Meanwhile, a new analysis finds that there is only limited room for improvement in terms of the agency’s speed for approving drugs.

FDA Commissioner Eyes New Drugmaker Rules, Including More Doctor Training On Opioids

Morning Briefing

Scott Gottlieb says the Food and Drug Administration will start to require that pharmaceutical companies offer more prescriber education for immediate-release opioids, which make up 90 percent of prescriptions.